Literature DB >> 26325420

Sphingosine-1-Phosphate Is a Crucial Signal for Migration of Retina Müller Glial Cells.

María V Simón, Facundo H Prado Spalm, Luis E Politi, Nora P Rotstein.   

Abstract

PURPOSE: Migration of Müller glial cells is enhanced in proliferative retinopathies, but the mechanisms involved are ill defined. Sphingosine-1-phosphate (S1P) is a bioactive sphingolipid synthesized by sphingosine kinase (SphK), which promotes proliferation, migration, and inflammation, acting as an intracellular mediator and activating a family of membrane receptors (S1PRs). We investigated whether S1P regulated glial migration.
METHODS: Müller glial cell cultures from rat retinas were supplemented with 5 μM S1P, and migration was evaluated by scratch-wound assays. Cultures were treated with SphK inhibitor 2 (SphKI 2), a SphK1 inhibitor, or with W146 and BML-241, S1P1 and S1P3 antagonists, respectively, to investigate whether Müller glial cells synthesized S1P and S1P-activated S1PRs to stimulate migration. The effects of LY294002, U0126, and SB203580, which are phosphatidylinositol-3 kinase (PI3K), extracellular signal regulated kinase/mitogen-activated protein kinase (ERK/MAPK), and p38 MAPK inhibitors, respectively, on glial migration were determined.
RESULTS: Sphingosine-1-phosphate addition prompted the formation of lamellipodia and enhanced glial migration. SphKI 2 almost completely prevented glial migration in controls; BML-241 inhibited this migration both in controls and in S1P-supplemented cultures, whereas W146 had no significant effect. Pretreatment with LY294002 and U0126 abrogated glial migration; SB203580 decreased it partially, although not significantly.
CONCLUSIONS: Our results suggest that Müller glial cells synthesize S1P, which signals through S1P3 and the PI3K and ERK/MAPK pathways to induce glial migration. As a whole, our data point to a central role for S1P in controlling glial cell motility. Because deregulation of this process is involved in several retinal pathologies, S1P signaling emerges as a potential tool for treating these diseases.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26325420     DOI: 10.1167/iovs.14-16195

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  6 in total

Review 1.  Regulations of Retinal Inflammation: Focusing on Müller Glia.

Authors:  Yingying Chen; Qinghong Xia; Yue Zeng; Yun Zhang; Meixia Zhang
Journal:  Front Cell Dev Biol       Date:  2022-04-27

2.  Cerebrovascular Angiogenic Reprogramming upon LRP1 Repression: Impact on Sphingosine-1-Phosphate-Mediated Signaling in Brain Endothelial Cell Chemotactism.

Authors:  Amélie Vézina; Cyndia Charfi; Alain Zgheib; Borhane Annabi
Journal:  Mol Neurobiol       Date:  2017-05-17       Impact factor: 5.590

3.  Shotgun Sphingolipid Analysis of Human Aqueous Humor.

Authors:  Anna Trzeciecka; Ulises Arbelo; Arturo Barron; Genea Edwards; Sruthi Sampathkumar; Carol Toris; Sanjoy K Bhattacharya
Journal:  Methods Mol Biol       Date:  2018

4.  The G-Protein-Coupled Chemoattractant Receptor Fpr2 Exacerbates High Glucose-Mediated Proinflammatory Responses of Müller Glial Cells.

Authors:  Ying Yu; Zhiyao Bao; Xiaofei Wang; Wanghua Gong; Hui Chen; Huaijin Guan; Yingying Le; Shaobo Su; Keqiang Chen; Ji Ming Wang
Journal:  Front Immunol       Date:  2017-12-19       Impact factor: 7.561

5.  Unravelling the interplay of sphingolipids and TGF-β signaling in the human corneal stroma.

Authors:  Sarah E Nicholas; Tyler G Rowsey; Shrestha Priyadarsini; Nawajes A Mandal; Dimitrios Karamichos
Journal:  PLoS One       Date:  2017-08-14       Impact factor: 3.240

6.  A Defective Crosstalk Between Neurons and Müller Glial Cells in the rd1 Retina Impairs the Regenerative Potential of Glial Stem Cells.

Authors:  Yanel A Volonté; Harmonie Vallese-Maurizi; Marcos J Dibo; Victoria B Ayala-Peña; Andrés Garelli; Samanta R Zanetti; Axel Turpaud; Cheryl Mae Craft; Nora P Rotstein; Luis E Politi; Olga L German
Journal:  Front Cell Neurosci       Date:  2019-07-25       Impact factor: 5.505

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.